Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients

Haematologica. 2023 Sep 1;108(9):2531-2534. doi: 10.3324/haematol.2022.282596.

¹ AP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; INSERM U976, Université Paris Cité, Paris.
² INSERM U944, Université Paris-Cité, Paris.
³ AP-HP, Hôpital Saint-Louis, Department of Haematology, Paris.
⁴ CH Versailles, Department of Haemato-Oncology, Versailles.
⁵ AP-HP, Hôpital Avicenne, Department of Haematology, Paris.
⁶ IGR, Department of Haematology, Villejuif.
⁷ AP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris.
⁸ AP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; INSERM U976, Université Paris Cité, Paris. lauriane.goldwirt@aphp.fr.

No abstract available

Publication types